HF
OLMA icon

HRT Financial’s Olema Pharmaceuticals OLMA Stock Holding History

HRT Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,266
Closed -$1.01M – 4461
2025
Q4 		$1.01M Buy
40,266
+23,975
+147% +$427K ﹤0.01% 1714
2025
Q3 		$159K Buy
+16,291
New +$97.8K ﹤0.01% 2456
2025
Q1 		– Sell
-41,198
Closed -$240K – 3145
2024
Q4 		$240K Sell
41,198
-67,654
-62% -$676K ﹤0.01% 1838
2024
Q3 		$1.3M Buy
+108,852
New +$1.39M 0.01% 1093
2023
Q2 		– Sell
-19,644
Closed -$68K – 3020
2023
Q1 		$68K Buy
+19,644
New +$80.1K ﹤0.01% 2106
2022
Q2 		– Sell
-84,870
Closed -$361K – 3495
2022
Q1 		$361K Sell
84,870
-11,919
-12% -$65.7K ﹤0.01% 2105
2021
Q4 		$905K Buy
+96,789
New +$2.01M 0.01% 1222
2021
Q1 		– Sell
-22,991
Closed -$1.1M – 3029
2020
Q4 		$1.1M Buy
+22,991
New +$1.08M 0.02% 572

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

HRT Financial's OLMA Position: Q1 2026 in Review

HRT Financial sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 40,266 shares — an estimated $1.01M sold.

HRT Financial first reported a position in OLMA in Q4 2020 and held it in 8 quarters. The position peaked at $1.3M in Q3 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • HRT Financial reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 40,266 Olema Pharmaceuticals shares in Q1 2026, an estimated $1.01M.
  • HRT Financial first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 8 quarters.
  • HRT Financial's Olema Pharmaceuticals position peaked at $1.3M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.